vs

Side-by-side financial comparison of INNO HOLDINGS INC. (INHD) and INVO Fertility, Inc. (IVF). Click either name above to swap in a different company.

INVO Fertility, Inc. is the larger business by last-quarter revenue ($1.8M vs $1.5M, roughly 1.2× INNO HOLDINGS INC.). INNO HOLDINGS INC. runs the higher net margin — -2.0% vs -150.5%, a 148.5% gap on every dollar of revenue. On growth, INNO HOLDINGS INC. posted the faster year-over-year revenue change (635.6% vs 22.6%).

INNOvative Retail BV, is an upmarket Belgian department store chain that operates sixteen branches around Belgium.

INVO Fertility, Inc. is a specialized healthcare company focused on delivering accessible assisted reproductive technology solutions. It develops, manufactures and markets the patented INVOcell intravaginal culture system for in vitro fertilization procedures, serving fertility clinics and patients across North America, Europe and other global regions, with a mission to reduce barriers to high-quality fertility care.

INHD vs IVF — Head-to-Head

Bigger by revenue
IVF
IVF
1.2× larger
IVF
$1.8M
$1.5M
INHD
Growing faster (revenue YoY)
INHD
INHD
+613.0% gap
INHD
635.6%
22.6%
IVF
Higher net margin
INHD
INHD
148.5% more per $
INHD
-2.0%
-150.5%
IVF

Income Statement — Q1 FY2026 vs Q3 FY2025

Metric
INHD
INHD
IVF
IVF
Revenue
$1.5M
$1.8M
Net Profit
$-28.6K
$-2.6M
Gross Margin
5.1%
Operating Margin
-33.4%
-93.1%
Net Margin
-2.0%
-150.5%
Revenue YoY
635.6%
22.6%
Net Profit YoY
95.3%
-62.2%
EPS (diluted)
$-0.01
$-0.77

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
INHD
INHD
IVF
IVF
Q4 25
$1.5M
Q3 25
$1.1M
$1.8M
Q2 25
$1.1M
$1.9M
Q1 25
$478.1K
$1.6M
Q4 24
$196.0K
$1.7M
Q3 24
$490.0K
$1.4M
Q2 24
$1.8M
Q1 24
$183.2K
$1.6M
Net Profit
INHD
INHD
IVF
IVF
Q4 25
$-28.6K
Q3 25
$-1.3M
$-2.6M
Q2 25
$-1.5M
$-5.3M
Q1 25
$-3.6M
$-17.4M
Q4 24
$-603.7K
$-3.6M
Q3 24
$-287.2K
$-1.6M
Q2 24
$-2.2M
Q1 24
$-1.1M
$-1.6M
Gross Margin
INHD
INHD
IVF
IVF
Q4 25
5.1%
Q3 25
1.3%
Q2 25
-1.5%
Q1 25
8.7%
35.2%
Q4 24
8.2%
41.4%
Q3 24
31.0%
Q2 24
53.1%
Q1 24
45.3%
Operating Margin
INHD
INHD
IVF
IVF
Q4 25
-33.4%
Q3 25
-89.7%
-93.1%
Q2 25
-143.7%
-160.4%
Q1 25
-286.4%
-1042.1%
Q4 24
-233.7%
-202.0%
Q3 24
87.7%
-90.7%
Q2 24
-100.9%
Q1 24
-150.9%
-95.7%
Net Margin
INHD
INHD
IVF
IVF
Q4 25
-2.0%
Q3 25
-120.5%
-150.5%
Q2 25
-142.4%
-283.6%
Q1 25
-757.3%
-1060.1%
Q4 24
-308.0%
-211.3%
Q3 24
-58.6%
-113.8%
Q2 24
-122.2%
Q1 24
-578.9%
-101.3%
EPS (diluted)
INHD
INHD
IVF
IVF
Q4 25
$-0.01
Q3 25
$5.03
$-0.77
Q2 25
$-0.30
$-13.30
Q1 25
$-0.83
$-12.53
Q4 24
$-5.21
$14.86
Q3 24
$-0.14
$-15.11
Q2 24
$-22.39
Q1 24
$-0.51
$-7.55

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
INHD
INHD
IVF
IVF
Cash + ST InvestmentsLiquidity on hand
$37.1M
Total DebtLower is stronger
$2.0M
Stockholders' EquityBook value
$47.2M
$5.8M
Total Assets
$47.3M
$18.8M
Debt / EquityLower = less leverage
0.34×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
INHD
INHD
IVF
IVF
Q4 25
$37.1M
Q3 25
$10.1M
Q2 25
$4.4M
Q1 25
$3.9M
Q4 24
$4.8M
Q3 24
$1.1M
Q2 24
Q1 24
$4.0M
Total Debt
INHD
INHD
IVF
IVF
Q4 25
Q3 25
$2.0M
Q2 25
$4.8M
Q1 25
Q4 24
$7.5M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
INHD
INHD
IVF
IVF
Q4 25
$47.2M
Q3 25
$15.2M
$5.8M
Q2 25
$8.0M
$2.6M
Q1 25
$7.1M
$3.3M
Q4 24
$9.4M
$12.7M
Q3 24
$2.8M
$-23.3K
Q2 24
$1.4M
Q1 24
$4.1M
$10.2K
Total Assets
INHD
INHD
IVF
IVF
Q4 25
$47.3M
Q3 25
$16.0M
$18.8M
Q2 25
$8.8M
$19.3M
Q1 25
$7.3M
$31.7M
Q4 24
$10.7M
$46.4M
Q3 24
$4.2M
$17.0M
Q2 24
$17.8M
Q1 24
$7.1M
$17.3M
Debt / Equity
INHD
INHD
IVF
IVF
Q4 25
Q3 25
0.34×
Q2 25
1.83×
Q1 25
Q4 24
0.59×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
INHD
INHD
IVF
IVF
Operating Cash FlowLast quarter
$-5.0M
$-1.8M
Free Cash FlowOCF − Capex
$-1.8M
FCF MarginFCF / Revenue
-101.6%
Capex IntensityCapex / Revenue
0.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-7.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
INHD
INHD
IVF
IVF
Q4 25
$-5.0M
Q3 25
$-1.0M
$-1.8M
Q2 25
$-594.8K
$-1.7M
Q1 25
$-1.0M
$-3.5M
Q4 24
$-2.1M
$-617.4K
Q3 24
$-660.2K
$-640.8K
Q2 24
$-1.5M
Q1 24
$-2.9M
$-260.6K
Free Cash Flow
INHD
INHD
IVF
IVF
Q4 25
Q3 25
$-1.8M
Q2 25
$-1.7M
Q1 25
$-3.6M
Q4 24
$-2.1M
$-696.3K
Q3 24
$-795.1K
Q2 24
$-1.5M
Q1 24
$-3.2M
$-310.3K
FCF Margin
INHD
INHD
IVF
IVF
Q4 25
Q3 25
-101.6%
Q2 25
-92.6%
Q1 25
-216.9%
Q4 24
-1083.3%
-40.6%
Q3 24
-162.3%
Q2 24
-82.3%
Q1 24
-1720.9%
-19.7%
Capex Intensity
INHD
INHD
IVF
IVF
Q4 25
Q3 25
0.5%
Q2 25
0.5%
Q1 25
0.9%
Q4 24
13.7%
4.6%
Q3 24
27.5%
0.0%
Q2 24
3.0%
Q1 24
118.1%
3.2%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons